{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:49:54Z","timestamp":1792799394664,"version":"4.5.0"},"reference-count":111,"publisher":"American Association for Cancer Research (AACR)","issue":"6","license":[{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":165,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015616","name":"Gray Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015616","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016394","name":"Ludwig Center at Harvard","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016394","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007477","name":"Canary Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007477","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U2C-CA233262"],"award-info":[{"award-number":["U2C-CA233262"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007316","name":"Division of Cancer Prevention, National Cancer Institute","doi-asserted-by":"publisher","award":["P50-CA228991"],"award-info":[{"award-number":["P50-CA228991"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-22-1-0852"],"award-info":[{"award-number":["W81XWH-22-1-0852"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005984","name":"Dr. Miriam and Sheldon G. Adelson Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005984","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006800","name":"Honorable Tina Brozman Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006800","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Mike and Patti Hennessy Foundation"},{"name":"Carl H. Goldsmith Ovarian Cancer Translational Research Fund"},{"name":"Bridge Project between the Koch Institute at MIT and DC\/HCC","id":[{"id":"https:\/\/ror.org\/059qmz715","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U01-CA284207"],"award-info":[{"award-number":["U01-CA284207"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007316","name":"Division of Cancer Prevention, National Cancer Institute","doi-asserted-by":"publisher","award":["U54-CA268072"],"award-info":[{"award-number":["U54-CA268072"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Program for Interdisciplinary Neuroscience"},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R50-CA274277"],"award-info":[{"award-number":["R50-CA274277"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"BWH President\u2019s Scholar award"}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>High-grade serous ovarian cancer (HGSOC) originates from fallopian tube (FT) precursors. However, the molecular changes that occur as precancerous lesions progress to HGSOC are not well understood. To address this, we integrated high-plex imaging and spatial transcriptomics to analyze human tissue samples at different stages of HGSOC development, including p53 signatures, serous tubal intraepithelial carcinomas (STIC), and invasive HGSOC. Our findings reveal immune modulating mechanisms within precursor epithelium, characterized by chromosomal instability, persistent IFN signaling, and dysregulated innate and adaptive immunity. FT precursors display elevated expression of MHC class I, including HLA-E, and IFN-stimulated genes, typically linked to later-stage tumorigenesis. These molecular alterations coincide with progressive shifts in the tumor microenvironment, transitioning from immune surveillance in early STICs to immune suppression in advanced STICs and cancer. These insights identify potential biomarkers and therapeutic targets for HGSOC interception and clarify the molecular transitions from precancer to cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>This study maps the immune response in FT precursors of HGSOC, highlighting localized IFN signaling, chromosomal instability, and competing immune surveillance and suppression along the progression axis. It provides an explorable public spatial profiling atlas for investigating precancer mechanisms, biomarkers, and early detection and interception strategies.<\/jats:p>\n                    <jats:p>See related commentary by Recouvreux and Orsulic, p. 1093<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2159-8290.cd-24-1366","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T08:57:38Z","timestamp":1734685058000},"page":"1180-1202","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Multimodal Spatial Profiling Reveals Immune Suppression and Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian Carcinoma"],"prefix":"10.1158","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1463-7593","authenticated-orcid":false,"given":"Tanjina","family":"Kader","sequence":"first","affiliation":[{"name":"1Laboratory of Systems Pharmacology, Harvard Medical School, Boston, Massachusetts."},{"name":"2Ludwig Center at Harvard, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4702-7705","authenticated-orcid":false,"given":"Jia-Ren","family":"Lin","sequence":"additional","affiliation":[{"name":"1Laboratory of Systems Pharmacology, Harvard Medical School, Boston, Massachusetts."},{"name":"2Ludwig Center at Harvard, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8299-3274","authenticated-orcid":false,"given":"Clemens B.","family":"Hug","sequence":"additional","affiliation":[{"name":"1Laboratory of Systems Pharmacology, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0033-9031","authenticated-orcid":false,"given":"Shannon","family":"Coy","sequence":"additional","affiliation":[{"name":"1Laboratory of Systems Pharmacology, Harvard Medical School, Boston, Massachusetts."},{"name":"2Ludwig Center at Harvard, Boston, Massachusetts."},{"name":"3Department of Pathology, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7228-4696","authenticated-orcid":false,"given":"Yu-An","family":"Chen","sequence":"additional","affiliation":[{"name":"1Laboratory of Systems Pharmacology, Harvard Medical School, Boston, Massachusetts."},{"name":"2Ludwig Center at Harvard, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5427-4750","authenticated-orcid":false,"given":"Ino","family":"de Bruijn","sequence":"additional","affiliation":[{"name":"4Memorial Sloan Kettering Cancer Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5025-1026","authenticated-orcid":false,"given":"Natalie","family":"Shih","sequence":"additional","affiliation":[{"name":"5Department of Obstetrics and Gynecology, Penn Ovarian Cancer Research Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1202-247X","authenticated-orcid":false,"given":"Euihye","family":"Jung","sequence":"additional","affiliation":[{"name":"5Department of Obstetrics and Gynecology, Penn Ovarian Cancer Research Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1957-5483","authenticated-orcid":false,"given":"Roxanne J.","family":"Pelletier","sequence":"additional","affiliation":[{"name":"1Laboratory of Systems Pharmacology, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4599-7719","authenticated-orcid":false,"given":"Mariana","family":"Lopez Leon","sequence":"additional","affiliation":[{"name":"1Laboratory of Systems Pharmacology, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7593-5885","authenticated-orcid":false,"given":"Gabriel","family":"Mingo","sequence":"additional","affiliation":[{"name":"5Department of Obstetrics and Gynecology, Penn Ovarian Cancer Research Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4323-2621","authenticated-orcid":false,"given":"Dalia K.","family":"Omran","sequence":"additional","affiliation":[{"name":"5Department of Obstetrics and Gynecology, Penn Ovarian Cancer Research Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4460-7118","authenticated-orcid":false,"given":"Jong Suk","family":"Lee","sequence":"additional","affiliation":[{"name":"1Laboratory of Systems Pharmacology, Harvard Medical School, Boston, Massachusetts."},{"name":"2Ludwig Center at Harvard, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1144-5710","authenticated-orcid":false,"given":"Clarence","family":"Yapp","sequence":"additional","affiliation":[{"name":"1Laboratory of Systems Pharmacology, Harvard Medical School, Boston, Massachusetts."},{"name":"2Ludwig Center at Harvard, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6608-345X","authenticated-orcid":false,"given":"Baby A.","family":"Satravada","sequence":"additional","affiliation":[{"name":"4Memorial Sloan Kettering Cancer Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6723-2859","authenticated-orcid":false,"given":"Ritika","family":"Kundra","sequence":"additional","affiliation":[{"name":"4Memorial Sloan Kettering Cancer Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5696-7475","authenticated-orcid":false,"given":"Yilin","family":"Xu","sequence":"additional","affiliation":[{"name":"1Laboratory of Systems Pharmacology, Harvard Medical School, Boston, Massachusetts."},{"name":"2Ludwig Center at Harvard, Boston, Massachusetts."},{"name":"3Department of Pathology, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4557-2972","authenticated-orcid":false,"given":"Sabrina","family":"Chan","sequence":"additional","affiliation":[{"name":"1Laboratory of Systems Pharmacology, Harvard Medical School, Boston, Massachusetts."},{"name":"2Ludwig Center at Harvard, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8826-665X","authenticated-orcid":false,"given":"Juliann B.","family":"Tefft","sequence":"additional","affiliation":[{"name":"1Laboratory of Systems Pharmacology, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0811-637X","authenticated-orcid":false,"given":"Jeremy L.","family":"Muhlich","sequence":"additional","affiliation":[{"name":"1Laboratory of Systems Pharmacology, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1381-6781","authenticated-orcid":false,"given":"Sarah H.","family":"Kim","sequence":"additional","affiliation":[{"name":"5Department of Obstetrics and Gynecology, Penn Ovarian Cancer Research Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6188-8523","authenticated-orcid":false,"given":"Stefan M.","family":"Gysler","sequence":"additional","affiliation":[{"name":"5Department of Obstetrics and Gynecology, Penn Ovarian Cancer Research Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3576-3169","authenticated-orcid":false,"given":"Judith","family":"Agudo","sequence":"additional","affiliation":[{"name":"6Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5356-4385","authenticated-orcid":false,"given":"James R.","family":"Heath","sequence":"additional","affiliation":[{"name":"7Institute of Systems Biology, Seattle, Washington."},{"name":"8Department of Bioengineering, University of Washington, Seattle, Washington."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0131-4904","authenticated-orcid":false,"given":"Nikolaus","family":"Schultz","sequence":"additional","affiliation":[{"name":"4Memorial Sloan Kettering Cancer Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6579-0416","authenticated-orcid":false,"given":"Charles W.","family":"Drescher","sequence":"additional","affiliation":[{"name":"9Swedish Cancer Institute Gynecologic Oncology and Pelvic Surgery, Seattle, Washington."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3364-1838","authenticated-orcid":false,"given":"Peter K.","family":"Sorger","sequence":"additional","affiliation":[{"name":"1Laboratory of Systems Pharmacology, Harvard Medical School, Boston, Massachusetts."},{"name":"2Ludwig Center at Harvard, Boston, Massachusetts."},{"name":"10Department of Systems Biology, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6912-6977","authenticated-orcid":false,"given":"Ronny","family":"Drapkin","sequence":"additional","affiliation":[{"name":"5Department of Obstetrics and Gynecology, Penn Ovarian Cancer Research Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania."},{"name":"11Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7528-9668","authenticated-orcid":false,"given":"Sandro","family":"Santagata","sequence":"additional","affiliation":[{"name":"1Laboratory of Systems Pharmacology, Harvard Medical School, Boston, Massachusetts."},{"name":"2Ludwig Center at Harvard, Boston, Massachusetts."},{"name":"3Department of Pathology, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts."},{"name":"10Department of Systems Biology, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2024,12,20]]},"reference":[{"key":"2025060303094930800_bib1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"2025060303094930800_bib2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/GCO.0000000000000340","article-title":"Pathogenesis and heterogeneity of ovarian cancer","volume":"29","author":"Kroeger","year":"2017","journal-title":"Curr Opin Obstet Gynecol"},{"key":"2025060303094930800_bib3","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nrc4019","article-title":"Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer","volume":"15","author":"Bowtell","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"2025060303094930800_bib4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J Pathol"},{"key":"2025060303094930800_bib5","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"2025060303094930800_bib6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"2025060303094930800_bib7","first-page":"292","article-title":"Incessant ovulation and ovarian cancer - a hypothesis re-visited","volume":"5","author":"Fathalla","year":"2013","journal-title":"Facts Views Vis Obgyn"},{"key":"2025060303094930800_bib8","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1477-7827-12-60","article-title":"The hormonal composition of follicular fluid and its implications for ovarian cancer pathogenesis","volume":"12","author":"Emori","year":"2014","journal-title":"Reprod Biol Endocrinol"},{"key":"2025060303094930800_bib9","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1200\/JCO.21.02016","article-title":"Risk of peritoneal carcinomatosis after risk-reducing salpingo-oophorectomy: a systematic review and individual patient data meta-analysis","volume":"40","author":"Steenbeek","year":"2022","journal-title":"J Clin Oncol"},{"key":"2025060303094930800_bib10","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ygyno.2018.11.033","article-title":"The fallopian tube,\u201cprecursor escape\u201d and narrowing the knowledge gap to the origins of high-grade serous carcinoma","volume":"152","author":"Soong","year":"2019","journal-title":"Gynecol Oncol"},{"key":"2025060303094930800_bib11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/path.5219","article-title":"Genomic landscape and evolutionary trajectories of ovarian cancer precursor lesions","volume":"248","author":"Wu","year":"2019","journal-title":"J Pathol"},{"key":"2025060303094930800_bib12","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1158\/2159-8290.CD-16-0607","article-title":"Genomics of ovarian cancer progression reveals diverse metastatic trajectories including intraepithelial metastasis to the fallopian tube","volume":"6","author":"Eckert","year":"2016","journal-title":"Cancer Discov"},{"key":"2025060303094930800_bib13","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41467-017-00962-1","article-title":"High grade serous ovarian carcinomas originate in the fallopian tube","volume":"8","author":"Labidi-Galy","year":"2017","journal-title":"Nat Commun"},{"key":"2025060303094930800_bib14","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/ng.3849","article-title":"Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes","volume":"49","author":"Wang","year":"2017","journal-title":"Nat Genet"},{"key":"2025060303094930800_bib15","doi-asserted-by":"crossref","first-page":"6536","DOI":"10.1158\/1078-0432.CCR-18-1199","article-title":"Methylomic analysis of ovarian cancers identifies tumor-specific alterations readily detectable in early precursor lesions","volume":"24","author":"Pisanic","year":"2018","journal-title":"Clin Cancer Res"},{"key":"2025060303094930800_bib16","doi-asserted-by":"crossref","first-page":"6310","DOI":"10.1158\/1078-0432.CCR-20-0270","article-title":"Methylomic landscapes of ovarian cancer precursor lesions","volume":"26","author":"Pisanic","year":"2020","journal-title":"Clin Cancer Res"},{"key":"2025060303094930800_bib17","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1158\/1541-7786.MCR-16-0097","article-title":"DNA methylome analyses implicate fallopian tube epithelia as the origin for high-grade serous ovarian cancer","volume":"14","author":"Klinkebiel","year":"2016","journal-title":"Mol Cancer Res"},{"key":"2025060303094930800_bib18","doi-asserted-by":"crossref","first-page":"zcad039","DOI":"10.1093\/narcan\/zcad039","article-title":"CDK2 regulates collapsed replication fork repair in CCNE1-amplified ovarian cancer cells via homologous recombination","volume":"5","author":"Brown","year":"2023","journal-title":"NAR Cancer"},{"key":"2025060303094930800_bib19","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1158\/0008-5472.CAN-13-2247","article-title":"Cyclin E1 deregulation occurs early in secretory cell transformation to promote formation of fallopian tube\u2013derived high-grade serous ovarian cancers","volume":"74","author":"Karst","year":"2014","journal-title":"Cancer Res"},{"key":"2025060303094930800_bib20","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/modpathol.2016.101","article-title":"CCNE1 amplification and centrosome number abnormality in serous tubal intraepithelial carcinoma: further evidence supporting its role as a precursor of ovarian high-grade serous carcinoma","volume":"29","author":"Kuhn","year":"2016","journal-title":"Mod Pathol"},{"key":"2025060303094930800_bib21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/path.6322","article-title":"The genomic trajectory of ovarian high-grade serous carcinoma can be observed in STIC lesions","volume":"264","author":"Cheng","year":"2024","journal-title":"J Pathol"},{"key":"2025060303094930800_bib22","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1158\/1078-0432.CCR-08-0196","article-title":"Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome","volume":"14","author":"Tothill","year":"2008","journal-title":"Clin Cancer Res"},{"key":"2025060303094930800_bib23","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1158\/1078-0432.CCR-22-0368","article-title":"Multiomic characterization of high-grade serous ovarian carcinoma enables high-resolution patient stratification","volume":"28","author":"Hollis","year":"2022","journal-title":"Clin Cancer Res"},{"key":"2025060303094930800_bib24","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/s41568-022-00503-z","article-title":"Immunobiology of high-grade serous ovarian cancer: lessons for clinical translation","volume":"22","author":"Kandalaft","year":"2022","journal-title":"Nat Rev Cancer"},{"key":"2025060303094930800_bib25","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s41586-022-05496-1","article-title":"Ovarian cancer mutational processes drive site-specific immune evasion","volume":"612","author":"V\u00e1zquez-Garc\u00eda","year":"2022","journal-title":"Nature"},{"key":"2025060303094930800_bib26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4110\/in.2015.15.1.16","article-title":"Immune cells in the female reproductive tract","volume":"15","author":"Lee","year":"2015","journal-title":"Immune Netw"},{"key":"2025060303094930800_bib27","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/PGP.0000000000000095","article-title":"Characterization of the immune cell repertoire in the normal fallopian tube","volume":"33","author":"Ardighieri","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"2025060303094930800_bib28","doi-asserted-by":"crossref","first-page":"e31657","DOI":"10.7554\/eLife.31657","article-title":"Highly multiplexed immunofluorescence imaging of human tissues and tumors using t-CyCIF and conventional optical microscopes","volume":"7","author":"Lin","year":"2018","journal-title":"Elife"},{"key":"2025060303094930800_bib29","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41580-023-00615-w","article-title":"The technological landscape and applications of single-cell multi-omics","volume":"24","author":"Baysoy","year":"2023","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2025060303094930800_bib30","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41576-019-0171-x","article-title":"Context is everything: aneuploidy in cancer","volume":"21","author":"Ben-David","year":"2020","journal-title":"Nat Rev Genet"},{"key":"2025060303094930800_bib31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1126\/science.959840","article-title":"The clonal evolution of tumor cell populations","volume":"194","author":"Nowell","year":"1976","journal-title":"Science"},{"key":"2025060303094930800_bib32","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41592-021-01308-y","article-title":"MCMICRO: a scalable, modular image-processing pipeline for multiplexed tissue imaging","volume":"19","author":"Schapiro","year":"2022","journal-title":"Nat Methods"},{"key":"2025060303094930800_bib33","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"Cancer Genome Atlas Research Network","year":"2011","journal-title":"Nature"},{"key":"2025060303094930800_bib34","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/path.2696","article-title":"Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary","volume":"221","author":"Ahmed","year":"2010","journal-title":"J Pathol"},{"key":"2025060303094930800_bib35","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"2025060303094930800_bib36","doi-asserted-by":"crossref","first-page":"D649","DOI":"10.1093\/nar\/gkx1132","article-title":"The reactome pathway knowledgebase","volume":"46","author":"Fabregat","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"2025060303094930800_bib37","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1038\/s41467-021-22800-1","article-title":"Decoupling epithelial-mesenchymal transitions from stromal profiles by integrative expression analysis","volume":"12","author":"Tyler","year":"2021","journal-title":"Nat Commun"},{"key":"2025060303094930800_bib38","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1038\/s41598-023-28480-9","article-title":"Cancer-associated fibroblasts are the main contributors to epithelial-to-mesenchymal signatures in the tumor microenvironment","volume":"13","author":"Szabo","year":"2023","journal-title":"Sci Rep"},{"key":"2025060303094930800_bib39","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1016\/j.cell.2023.07.036","article-title":"TGF-\u03b2 signaling in health and disease","volume":"186","author":"Massagu\u00e9","year":"2023","journal-title":"Cell"},{"key":"2025060303094930800_bib40","doi-asserted-by":"crossref","first-page":"18490","DOI":"10.1073\/pnas.0809242105","article-title":"An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer","volume":"105","author":"Weichselbaum","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025060303094930800_bib41","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.trecan.2022.09.003","article-title":"How cancer cells make and respond to interferon-I","volume":"9","author":"Cheon","year":"2023","journal-title":"Trends Cancer"},{"key":"2025060303094930800_bib42","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/s41586-023-06421-w","article-title":"Interferon-\u03b5 is a tumour suppressor and restricts ovarian cancer","volume":"620","author":"Marks","year":"2023","journal-title":"Nature"},{"key":"2025060303094930800_bib43","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s44321-023-00018-6","article-title":"Interferon-epsilon is a novel regulator of NK cell responses in the uterus","volume":"16","author":"Mayall","year":"2024","journal-title":"EMBO Mol Med"},{"key":"2025060303094930800_bib44","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/bmsp.12195","article-title":"Modelling monotonic effects of ordinal predictors in Bayesian regression models","volume":"73","author":"B\u00fcrkner","year":"2020","journal-title":"Br J Math Stat Psychol"},{"key":"2025060303094930800_bib45","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1084\/jem.187.5.813","article-title":"Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence\u2013derived peptides by CD94\/NKG2 confers protection from natural killer cell\u2013mediated lysis","volume":"187","author":"Borrego","year":"1998","journal-title":"J Exp Med"},{"key":"2025060303094930800_bib46","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.1158\/1078-0432.CCR-19-2095","article-title":"The NKG2A-HLA-E axis as a novel checkpoint in the tumor microenvironment","volume":"26","author":"Borst","year":"2020","journal-title":"Clin Cancer Res"},{"key":"2025060303094930800_bib47","first-page":"633","article-title":"Human leukocyte antigen-E protein is overexpressed in primary human colorectal cancer","volume":"32","author":"Levy","year":"2008","journal-title":"Int J Oncol"},{"key":"2025060303094930800_bib48","doi-asserted-by":"crossref","first-page":"67360","DOI":"10.18632\/oncotarget.11744","article-title":"HLA-E expression and its clinical relevance in human renal cell carcinoma","volume":"7","author":"Seliger","year":"2016","journal-title":"Oncotarget"},{"key":"2025060303094930800_bib49","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s13048-023-01286-z","article-title":"IFN\u03b3 in ovarian tumor microenvironment upregulates HLA-E expression and predicts a poor prognosis","volume":"16","author":"Zheng","year":"2023","journal-title":"J Ovarian Res"},{"key":"2025060303094930800_bib50","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00251-019-01106-z","article-title":"Class I transactivator, NLRC5: a central player in the MHC class I pathway and cancer immune surveillance","volume":"71","author":"Vijayan","year":"2019","journal-title":"Immunogenetics"},{"key":"2025060303094930800_bib51","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-I- and type-II-interferon-mediated signalling","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"2025060303094930800_bib52","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1126\/science.1233321","article-title":"Interferon-\u03b5 protects the female reproductive tract from viral and bacterial infection","volume":"339","author":"Fung","year":"2013","journal-title":"Science"},{"key":"2025060303094930800_bib53","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1073\/pnas.0308102100","article-title":"STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells","volume":"101","author":"Khodarev","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025060303094930800_bib54","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.cell.2022.12.028","article-title":"Multiplexed 3D atlas of state transitions and immune interaction in colorectal cancer","volume":"186","author":"Lin","year":"2023","journal-title":"Cell"},{"key":"2025060303094930800_bib55","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/cjp2.230","article-title":"STING pathway expression in low-grade serous carcinoma of the ovary: an unexpected therapeutic opportunity?","volume":"7","author":"Huvila","year":"2021","journal-title":"J Pathol Clin Res"},{"key":"2025060303094930800_bib56","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41588-023-01320-2","article-title":"Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancer","volume":"55","author":"Burdett","year":"2023","journal-title":"Nat Genet"},{"key":"2025060303094930800_bib57","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa1616288","article-title":"Tracking the evolution of non-small-cell lung cancer","volume":"376","author":"Jamal-Hanjani","year":"2017","journal-title":"N Engl J Med"},{"key":"2025060303094930800_bib58","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41568-020-0272-z","article-title":"The cancer\u2013natural killer cell immunity cycle","volume":"20","author":"Huntington","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"2025060303094930800_bib59","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.3390\/vaccines10121993","article-title":"Disruption of the NKG2A:HLA-E immune checkpoint axis to enhance NK cell activation against cancer","volume":"10","author":"Fisher","year":"2022","journal-title":"Vaccines"},{"key":"2025060303094930800_bib60","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.cell.2018.10.014","article-title":"Anti-NKG2A mAb is a checkpoint inhibitor that promotes anti-tumor immunity by unleashing both T and NK cells","volume":"175","author":"Andr\u00e9","year":"2018","journal-title":"Cell"},{"key":"2025060303094930800_bib61","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ccell.2023.01.001","article-title":"Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance","volume":"41","author":"Liu","year":"2023","journal-title":"Cancer Cell"},{"key":"2025060303094930800_bib62","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.ccell.2022.08.005","article-title":"NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer","volume":"40","author":"Salom\u00e9","year":"2022","journal-title":"Cancer Cell"},{"key":"2025060303094930800_bib63","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature14493","article-title":"Chromothripsis from DNA damage in micronuclei","volume":"522","author":"Zhang","year":"2015","journal-title":"Nature"},{"key":"2025060303094930800_bib64","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nature23449","article-title":"cGAS surveillance of micronuclei links genome instability to innate immunity","volume":"548","author":"Mackenzie","year":"2017","journal-title":"Nature"},{"key":"2025060303094930800_bib65","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1186\/s12885-018-4347-0","article-title":"Active DNA end processing in micronuclei of ovarian cancer cells","volume":"18","author":"Tang","year":"2018","journal-title":"BMC Cancer"},{"key":"2025060303094930800_bib66","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/s41598-023-28840-5","article-title":"LINE-1 ORF1p as a candidate biomarker in high grade serous ovarian carcinoma","volume":"13","author":"Sato","year":"2023","journal-title":"Sci Rep"},{"key":"2025060303094930800_bib67","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ajpath.2018.11.005","article-title":"Long interspersed nuclear element 1 retrotransposons become deregulated during the development of ovarian cancer precursor lesions","volume":"189","author":"Pisanic","year":"2019","journal-title":"Am J Pathol"},{"key":"2025060303094930800_bib68","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41586-018-0784-9","article-title":"L1 drives IFN in senescent cells and promotes age-associated inflammation","volume":"566","author":"De Cecco","year":"2019","journal-title":"Nature"},{"key":"2025060303094930800_bib69","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.humpath.2019.06.001","article-title":"Expression of L1 retrotransposon open reading frame protein 1 in gynecologic cancers","volume":"92","author":"Xia","year":"2019","journal-title":"Hum Pathol"},{"key":"2025060303094930800_bib70","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/s41588-018-0179-8","article-title":"Copy number signatures and mutational processes in ovarian carcinoma","volume":"50","author":"Macintyre","year":"2018","journal-title":"Nat Genet"},{"key":"2025060303094930800_bib71","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41586-022-04847-2","article-title":"cGAS\u2013STING drives the IL-6-dependent survival of chromosomally instable cancers","volume":"607","author":"Hong","year":"2022","journal-title":"Nature"},{"key":"2025060303094930800_bib72","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nature25432","article-title":"Chromosomal instability drives metastasis through a cytosolic DNA response","volume":"553","author":"Bakhoum","year":"2018","journal-title":"Nature"},{"key":"2025060303094930800_bib73","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1172\/JCI87724","article-title":"Mutant p53 establishes targetable tumor dependency by promoting unscheduled replication","volume":"127","author":"Singh","year":"2017","journal-title":"J Clin Invest"},{"key":"2025060303094930800_bib74","doi-asserted-by":"crossref","first-page":"103780","DOI":"10.1016\/j.critrevonc.2022.103780","article-title":"Potential role of cGAS\/STING pathway in regulating cancer progression","volume":"178","author":"Dhanisha","year":"2022","journal-title":"Crit Rev Oncol Hematol"},{"key":"2025060303094930800_bib75","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1158\/2159-8290.CD-21-1357","article-title":"The spatial landscape of progression and immunoediting in primary melanoma at single-cell resolution","volume":"12","author":"Nirmal","year":"2022","journal-title":"Cancer Discov"},{"key":"2025060303094930800_bib76","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s43018-023-00576-1","article-title":"High-plex immunofluorescence imaging and traditional histology of the same tissue section for discovering image-based biomarkers","volume":"4","author":"Lin","year":"2023","journal-title":"Nat Cancer"},{"key":"2025060303094930800_bib77","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.trecan.2018.09.001","article-title":"The role of type 1 conventional dendritic cells in cancer immunity","volume":"4","author":"B\u00f6ttcher","year":"2018","journal-title":"Trends Cancer"},{"key":"2025060303094930800_bib78","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.cell.2018.01.004","article-title":"NK cells stimulate recruitment of cDC1 into the tumor microenvironment promoting cancer immune control","volume":"172","author":"B\u00f6ttcher","year":"2018","journal-title":"Cell"},{"key":"2025060303094930800_bib79","doi-asserted-by":"crossref","first-page":"13720","DOI":"10.1038\/ncomms13720","article-title":"The tumour microenvironment harbours ontogenically distinct dendritic cell populations with opposing effects on tumour immunity","volume":"7","author":"Laoui","year":"2016","journal-title":"Nat Commun"},{"key":"2025060303094930800_bib80","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41571-024-00859-1","article-title":"Dendritic cells as orchestrators of anticancer immunity and immunotherapy","volume":"21","author":"Heras-Murillo","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"2025060303094930800_bib81","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s41591-018-0085-8","article-title":"A natural killer\u2013dendritic cell axis defines checkpoint therapy\u2013responsive tumor microenvironments","volume":"24","author":"Barry","year":"2018","journal-title":"Nat Med"},{"key":"2025060303094930800_bib82","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41568-023-00635-w","article-title":"How chemokines organize the tumour microenvironment","volume":"24","author":"Mempel","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"2025060303094930800_bib83","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s12094-017-1686-2","article-title":"Influence of ovarian cancer type I and type II microenvironment on the phenotype and function of monocyte-derived dendritic cells","volume":"19","author":"Sur\u00f3wka","year":"2017","journal-title":"Clin Transl Oncol"},{"key":"2025060303094930800_bib84","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/s41422-020-0355-0","article-title":"A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling","volume":"30","author":"Qian","year":"2020","journal-title":"Cell Res"},{"key":"2025060303094930800_bib85","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ccell.2017.11.019","article-title":"TIM-3 regulates CD103+ dendritic cell function and response to chemotherapy in breast cancer","volume":"33","author":"de Mingo Pulido","year":"2018","journal-title":"Cancer Cell"},{"key":"2025060303094930800_bib86","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.immuni.2021.04.019","article-title":"The inhibitory receptor TIM-3 limits activation of the cGAS-STING pathway in intra-tumoral dendritic cells by suppressing extracellular DNA uptake","volume":"54","author":"de Mingo Pulido","year":"2021","journal-title":"Immunity"},{"key":"2025060303094930800_bib87","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jri.2016.10.113","article-title":"Tim-3: expression on immune cells and roles at the maternal-fetal interface","volume":"118","author":"Hu","year":"2016","journal-title":"J Reprod Immunol"},{"key":"2025060303094930800_bib88","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/ni.2376","article-title":"Tumor-infiltrating DCs suppress nucleic acid\u2013mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1","volume":"13","author":"Chiba","year":"2012","journal-title":"Nat Immunol"},{"key":"2025060303094930800_bib89","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.it.2019.06.002","article-title":"Tissue-resident memory T cells in cancer immunosurveillance","volume":"40","author":"Park","year":"2019","journal-title":"Trends Immunol"},{"key":"2025060303094930800_bib90","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nri.2015.3","article-title":"Tissue-resident memory T cells: local specialists in immune defence","volume":"16","author":"Mueller","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"2025060303094930800_bib91","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.canlet.2017.12.003","article-title":"The role of STAT3 in leading the crosstalk between human cancers and the immune system","volume":"415","author":"Wang","year":"2018","journal-title":"Cancer Lett"},{"key":"2025060303094930800_bib92","doi-asserted-by":"crossref","first-page":"6069","DOI":"10.1038\/s41467-024-50137-y","article-title":"Timing of whole genome duplication is associated with tumor-specific MHC-II depletion in serous ovarian cancer","volume":"15","author":"Burdett","year":"2024","journal-title":"Nat Commun"},{"key":"2025060303094930800_bib93","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1158\/1078-0432.CCR-23-0932","article-title":"Aneuploidy landscape in precursors of ovarian cancer","volume":"30","author":"Wang","year":"2024","journal-title":"Clin Cancer Res"},{"key":"2025060303094930800_bib94","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/PAS.0000000000002187","article-title":"Morphologic and molecular heterogeneity of high-grade serous carcinoma precursor lesions","volume":"48","author":"Chien","year":"2024","journal-title":"Am J Surg Pathol"},{"key":"2025060303094930800_bib95","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41586-020-1969-6","article-title":"Pan-cancer analysis of whole genomes","volume":"578","author":"ICGC\/TCGA Pan-Cancer Analysis of Whole Genomes Consortium","year":"2020","journal-title":"Nature"},{"key":"2025060303094930800_bib96","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s43018-024-00796-z","article-title":"p53 at the crossroads of tumor immunity","volume":"5","author":"Efe","year":"2024","journal-title":"Nat Cancer"},{"key":"2025060303094930800_bib97","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/bjc.1949.13","article-title":"An experimental study of the initiating state of carcinogenesis, and a re-examination of the somatic cell mutation theory of cancer","volume":"3","author":"Berenblum","year":"1949","journal-title":"Br J Cancer"},{"key":"2025060303094930800_bib98","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s10654-022-00933-x","article-title":"Peto\u2019s paradox revisited: black box vs mechanistic approaches to understanding the roles of mutations and promoting factors in cancer","volume":"38","author":"Balmain","year":"2023","journal-title":"Eur J Epidemiol"},{"key":"2025060303094930800_bib99","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/bjc.1949.42","article-title":"The persistence of latent tumour cells induced in the mouse\u2019s skin by a single application of 9:10-dimethyl-1:2-benzanthracene","volume":"3","author":"Berenblum","year":"1949","journal-title":"Br J Cancer"},{"key":"2025060303094930800_bib100","doi-asserted-by":"crossref","first-page":"10154","DOI":"10.3390\/ijms241210154","article-title":"Effects of follicular fluid on physiological characteristics and differentiation of fallopian tube epithelial cells implicating for ovarian cancer pathogenesis","volume":"24","author":"Zhu","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2025060303094930800_bib101","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1158\/2159-8290.CD-23-1550","article-title":"The hallmarks of precancer","volume":"14","author":"Stangis","year":"2024","journal-title":"Cancer Discov"},{"key":"2025060303094930800_bib102","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1158\/1940-6207.CAPR-22-0478","article-title":"Worth a pound of cure? Emerging strategies and challenges in cancer immunoprevention","volume":"16","author":"Haldar","year":"2023","journal-title":"Cancer Prev Res (Phila)"},{"key":"2025060303094930800_bib103","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1093\/bioinformatics\/btac544","article-title":"Stitching and registering highly multiplexed whole-slide images of tissues and tumors using ASHLAR","volume":"38","author":"Muhlich","year":"2022","journal-title":"Bioinformatics"},{"key":"2025060303094930800_bib104","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/s42003-022-04076-3","article-title":"UnMICST: deep learning with real augmentation for robust segmentation of highly multiplexed images of human tissues","volume":"5","author":"Yapp","year":"2022","journal-title":"Commun Biol"},{"key":"2025060303094930800_bib105","first-page":"378","article-title":"glmmTMB balances speed and flexibility among packages for zero-inflated generalized linear mixed modeling","volume":"9","author":"Brooks","year":"2017","journal-title":"R Journal"},{"key":"2025060303094930800_bib106","doi-asserted-by":"crossref","first-page":"e616","DOI":"10.7717\/peerj.616","article-title":"Using observation-level random effects to model overdispersion in count data in ecology and evolution","volume":"2","author":"Harrison","year":"2014","journal-title":"PeerJ"},{"key":"2025060303094930800_bib107","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nmeth.4391","article-title":"histoCAT: analysis of cell phenotypes and interactions in multiplex image cytometry data","volume":"14","author":"Schapiro","year":"2017","journal-title":"Nat Methods"},{"key":"2025060303094930800_bib108","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1109\/ICCV.2011.6126544","article-title":"ORB: an efficient alternative to SIFT or SURF","volume-title":"2011 International Conference on Computer Vision [Internet]","author":"Rublee","year":"2011"},{"key":"2025060303094930800_bib109","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/s41586-021-04278-5","article-title":"Multi-omic machine learning predictor of breast cancer therapy response","volume":"601","author":"Sammut","year":"2022","journal-title":"Nature"},{"key":"2025060303094930800_bib110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v080.i01","article-title":"brms: an R package for Bayesian multilevel models using stan","volume":"80","author":"B\u00fcrkner","year":"2017","journal-title":"J Stat Softw"},{"key":"2025060303094930800_bib111","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3758\/s13423-016-1221-4","article-title":"The Bayesian New Statistics: hypothesis testing, estimation, meta-analysis, and power analysis from a Bayesian perspective","volume":"25","author":"Kruschke","year":"2018","journal-title":"Psychon Bull Rev"}],"container-title":["Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/doi\/10.1158\/2159-8290.CD-24-1366\/3526358\/cd-24-1366.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/doi\/10.1158\/2159-8290.CD-24-1366\/3603149\/cd-24-1366.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/15\/6\/1180\/3610082\/cd-24-1366.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/15\/6\/1180\/3610082\/cd-24-1366.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T03:10:18Z","timestamp":1748920218000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article\/15\/6\/1180\/762591\/Multimodal-Spatial-Profiling-Reveals-Immune"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,20]]},"references-count":111,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,12,20]]},"published-print":{"date-parts":[[2025,6,3]]}},"URL":"https:\/\/doi.org\/10.1158\/2159-8290.cd-24-1366","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2159-8290.29221703","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.29221715","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.29221679","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.29221688","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.29221706","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.29221700","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.29221712","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.29221718","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.29221709","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.29221694","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.29221682","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.29221691","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.29221697","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.29221685","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2159-8290.c.7854107","asserted-by":"object"},{"id-type":"doi","id":"10.1101\/2024.09.25.615007","asserted-by":"object"}]},"ISSN":["2159-8274","2159-8290"],"issn-type":[{"value":"2159-8274","type":"print"},{"value":"2159-8290","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,20]]}}}